Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
WhiteOak Capital Pharma and Healthcare Fund Reg (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 06-Feb-24
Corpus(Cr.) 902.00 Latest NAV 16.49 As on 29-10-2026
Equity(%) 90.72 52 Week High 17.165
Debt(%) 9.28 52 Week Low 12.931
Others(%) 0.00 Exit Load 0
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Ramesh Mantri
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 31.19%
Top 10 Holdings 47.59%
Top 25 Holdings 76.34%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 61.16
Healthcare 24.38
Cash 6.13
Chemicals 3.34
SOV 3.15
Consumer Durables 1.84
 
 
 
 
 
Portfolio Metrics
PB Ratio 7.73
PE Ratio 53.02
 
Top 25 Holdings
Holdings Net Asset(%)
Divis Laboratories Ltd. 8.36
Sun Pharmaceutical Industries Ltd. 7.11
Torrent Pharmaceuticals Ltd. 6.26
Clearing Corporation of India Ltd 5.55
Laurus Labs Limited 3.91
Apollo Hospitals Enterprises Ltd. 3.75
Cipla Ltd. 3.68
Sai Life Sciences Limited 3.28
Ipca Laboratories Ltd. 2.88
Zydus Lifesciences Limited 2.81
Neuland Laboratories Limited. 2.60
Dr. Lal Pathlabs Limited 2.35
Corona Remedies Limited 2.34
Thyrocare Technologies Limited 2.27
Aurobindo Pharma Ltd. 2.09
Ajanta Pharma Ltd. 2.01
Krishna Institute of Medical Sciences Limited 1.85
Max Healthcare Institute Limited 1.84
Shaily Engineering Plastics Ltd. 1.84
Global Health Limited 1.82
Narayana Hrudayalaya Limited 1.61
Anthem Biosciences Limited 1.57
Vijaya Diagnostic Centre Limited 1.56
Onesource Specialty Pharma Limited 1.55
ACUTAAS CHEMICALS LIMITED 1.45

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-1.89% -0.24% 15.97% 16.23%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-2.23% -2.98% 8.71% 8.99%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
13.42% 0.00% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
6.75% 21.05% 14.18% 10.60%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
WhiteOak Capital Pharma and Healthcare Fund Reg (G) 0.00% 0.0000 0.0000% 0.0000 0.0000
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
WhiteOak Capital Pharma and Healthcare Fund Reg (G) 0.0000% 0.0000 0.0000 0.0000 0.0000
 
Back to Selection